The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global probiotic dietary supplement market size reached US$ 6.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2027, exhibiting a growth rate (CAGR) of 7.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Probiotic dietary supplements are natural and herbal nutritional compounds consisting of live microbial ingredients. They consist of a combination of live bacteria and yeast to improve the functioning of the gut, intestines and digestive system. These supplements are a rich source of good bacteria and yeast, such as Lactobacillus, Bifidobacterium and Saccharomyces Boulardii, that aid in reinforcing the immune system and controlling inflammation in the body. The supplements are commonly available in the form of powder stick packs, capsules, tablets and probiotic drops and are usually used in food and nutritional supplements, infant formulas and animal feed.
The rising prevalence of gastrointestinal ailments, such as irritable bowel syndrome, inflammatory bowel disease and diarrhea, across the globe is one of the factors driving the market growth. Probiotic dietary supplements are highly beneficial in improving nutrient absorption and preventing the onset of various medical ailments, such as cancer, tooth decay and neurological disorders. Moreover, increasing consumer awareness regarding the benefits of regular consumption of health supplements to prevent illnesses is providing a thrust to the market growth. In line with this, the onset of the coronavirus (COVID-19) pandemic has positively impacted the demand for probiotic dietary supplements to improve the immunity and prevent respiratory infections. Additionally, various product innovations, such as the development of extended-release and sugar-, dairy- and allergen-free formulations, are contributing to the growth of the market. Other factors, including extensive research and development (R&D) activities to identify the novel strains of probiotics, along with the rising geriatric population, which is more susceptible to digestive ailments, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global probiotic dietary supplement market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on form, distribution channel and application.
Breakup by Form:
Breakup by Distribution Channel:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BioGaia, Chr. Hansen Holding A/S, Custom Probiotics Inc., Dietary Pro Labs, Koninklijke DSM N.V., NutraScience Labs (Twinlab Consolidated Holdings Inc.), Probi USA Inc. (Symrise AG), ProbioFerm, Protexin (Archer-Daniels-Midland Company), Reckitt Benckiser Group plc and Vitakem Nutraceuticals Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Form, Distribution Channel, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||BioGaia, Chr. Hansen Holding A/S, Custom Probiotics Inc., Dietary Pro Labs, Koninklijke DSM N.V., NutraScience Labs (Twinlab Consolidated Holdings Inc.), Probi USA Inc. (Symrise AG), ProbioFerm, Protexin (Archer-Daniels-Midland Company), Reckitt Benckiser Group plc and Vitakem Nutraceuticals Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at